JESSICA NOE: Open Payments
NPI 1104443480 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,936 in 64 payments from 12 companies in 2025. Trend: 2023 $293 · 2024 $1,083 · 2025 $1,936
Food & beverage: $1,936
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $434 |
| Novartis Pharmaceuticals Corporation | 19 | $269 |
| PFIZER INC. | 11 | $264 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $201 |
| Penumbra, Inc. | 1 | $152 |
| Boston Scientific Corporation | 1 | $145 |
| Actelion Pharmaceuticals US, Inc. | 2 | $140 |
| E.R. Squibb & Sons, L.L.C. | 11 | $138 |
| Novo Nordisk Inc | 2 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
Products named: REPATHA, LEQVIO, Kerendia, VYNDAQEL, Penumbra System, ELIQUIS, WATCHMAN Access System, UPTRAVI.
Industry payments across KY — which companies pay providers there.
